Joshua M Barnett1, Sandra Suarez2, Gary W McCollum3, John S Penn1. 1. Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States. 2. Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States. 3. Department of Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, Nashville, Tennessee, United States.
Abstract
PURPOSE: We investigated endoglin expression in hypoxic microvascular endothelial cells and retinal endoglin expression in rats that develop experimental oxygen-induced retinopathy (OIR). We also tested neutralizing antibodies (Abs) against endoglin (anti-CD105 Ab) and VEGF (anti-VEGF Ab) either alone or in combination for efficacy against serum-induced retinal microvascular endothelial cell proliferation and retinal neovascularization (NV) in OIR rats. To our knowledge, this marks the first time that a biologic agent has been used to target retinal endoglin and modulate retinal neovascularization. METHODS: Induction of endoglin by hypoxia was measured by immunohistochemical analysis and ELISA. Proliferation was quantified using a colorimetric 5-bromo-2-deoxyuridine ELISA. Western blots were used to measure endoglin levels in retinas of OIR rats. Immunohistochemical staining was also preformed in OIR rats using anti-CD105 and fluorescein isothiocyanate-conjugated isolectin B4 antibodies. RESULTS: Anti-CD105 Ab and Anti-VEGF Ab, administered alone or in combination, reduced serum-induced retinal microvascular endothelial cell proliferation. Additionally, in a rat model of oxygen-induced retinopathy, retinal endoglin was significantly increased at 14(2), 14(3), 14(4) and 14(6) compared with retinal levels in control rats. At 14(2), immunohistochemical analysis demonstrated that endoglin was elevated in newly developed vessels at the peripheral extent of major veins, precisely where NV is expected to develop in OIR rats. Neutralizing anti-CD105 reduced retinal NV in OIR rats. CONCLUSIONS: Our data support other studies showing that reduction of endoglin expression inhibits retinal NV. Our findings demonstrate that retinal endoglin immunolocalization overlaps with nascent neovascular structures in OIR rats. Therefore, endoglin may serve as a useful predictor of incipient neovascular disease. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: We investigated endoglin expression in hypoxic microvascular endothelial cells and retinal endoglin expression in rats that develop experimental oxygen-induced retinopathy (OIR). We also tested neutralizing antibodies (Abs) against endoglin (anti-CD105 Ab) and VEGF (anti-VEGF Ab) either alone or in combination for efficacy against serum-induced retinal microvascular endothelial cell proliferation and retinal neovascularization (NV) in OIR rats. To our knowledge, this marks the first time that a biologic agent has been used to target retinal endoglin and modulate retinal neovascularization. METHODS: Induction of endoglin by hypoxia was measured by immunohistochemical analysis and ELISA. Proliferation was quantified using a colorimetric 5-bromo-2-deoxyuridine ELISA. Western blots were used to measure endoglin levels in retinas of OIR rats. Immunohistochemical staining was also preformed in OIR rats using anti-CD105 and fluorescein isothiocyanate-conjugated isolectin B4 antibodies. RESULTS: Anti-CD105 Ab and Anti-VEGF Ab, administered alone or in combination, reduced serum-induced retinal microvascular endothelial cell proliferation. Additionally, in a rat model of oxygen-induced retinopathy, retinal endoglin was significantly increased at 14(2), 14(3), 14(4) and 14(6) compared with retinal levels in control rats. At 14(2), immunohistochemical analysis demonstrated that endoglin was elevated in newly developed vessels at the peripheral extent of major veins, precisely where NV is expected to develop in OIR rats. Neutralizing anti-CD105 reduced retinal NV in OIR rats. CONCLUSIONS: Our data support other studies showing that reduction of endoglin expression inhibits retinal NV. Our findings demonstrate that retinal endoglin immunolocalization overlaps with nascent neovascular structures in OIR rats. Therefore, endoglin may serve as a useful predictor of incipient neovascular disease. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Entities:
Keywords:
angiogenesis; early diagnostic biomarker; retinal neovascularization
Authors: Tom A Gardiner; David S Gibson; Tanyth E de Gooyer; Vidal F de la Cruz; Denise M McDonald; Alan W Stitt Journal: Am J Pathol Date: 2005-02 Impact factor: 4.307
Authors: Luis Arias; Jose M Caminal; Maria B Badia; Marcos J Rubio; Jaume Catala; Octavio Pujol Journal: Retina Date: 2010 Nov-Dec Impact factor: 4.256
Authors: Zhen Liu; Franck Lebrin; Janita A Maring; Sander van den Driesche; Stieneke van der Brink; Maarten van Dinther; Midory Thorikay; Sabrina Martin; Kazuki Kobayashi; Lukas J A C Hawinkels; Laurens A van Meeteren; Evangelia Pardali; Jeroen Korving; Michelle Letarte; Helen M Arthur; Charles Theuer; Marie-José Goumans; Christine Mummery; Peter ten Dijke Journal: PLoS One Date: 2014-01-28 Impact factor: 3.240
Authors: Yingmiao Liu; Hongyu Tian; Gerard C Blobe; Charles P Theuer; Herbert I Hurwitz; Andrew B Nixon Journal: Invest New Drugs Date: 2014-07-05 Impact factor: 3.850
Authors: Steven Droho; Benjamin R Thomson; Hadijat M Makinde; Carla M Cuda; Harris Perlman; Jeremy A Lavine Journal: J Neuroinflammation Date: 2020-11-13 Impact factor: 8.322
Authors: Marina Martínez-Carmona; Fernando Lucas-Ruiz; Alejandro Gallego-Ortega; Caridad Galindo-Romero; María Norte-Muñoz; María José González-Riquelme; Francisco J Valiente-Soriano; Manuel Vidal-Sanz; Marta Agudo-Barriuso Journal: Int J Mol Sci Date: 2021-12-21 Impact factor: 5.923
Authors: Claudia Ollauri-Ibáñez; Elena Núñez-Gómez; Cristina Egido-Turrión; Laura Silva-Sousa; Elena Díaz-Rodríguez; Alicia Rodríguez-Barbero; José M López-Novoa; Miguel Pericacho Journal: Angiogenesis Date: 2020-01-03 Impact factor: 9.596